Qin Li

Qin Li has a strong background in translational pharmacology and oncology. They started their career at Moores Cancer Center as a Postdoctoral Scholar, where they focused on researching glioblastomas and identifying a novel angiogenic factor. Qin then moved on to BioDuro-Sundia, where they held roles as a Senior Oncology Scientist and later as an Associate Director in Oncology. Currently, Qin is working at Shoreline Biosciences, Inc. as a Sr. Scientist and has been promoted to the role of Principal Scientist in Translational Pharmacology.

Qin Li completed a Bachelor of Science (B.S.) in Biotechnology from Beijing Normal University, followed by a Master of Science (M.S.) in Biochemistry from the University of Saskatchewan. Qin then obtained a Doctor of Philosophy (Ph.D.) in Genetics from UT MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences in 2013.